M&T Bank
MDGL icon

M&T Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

M&T Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$405K Sell
803
-11
-1% -$5.81K ﹤0.01% 1299
2026
Q2 		$438K Buy
814
+232
+40% +$119K ﹤0.01% 1274
2026
Q1 		$305K Sell
582
-47
-7% -$22.5K ﹤0.01% 1373
2025
Q4 		$366K Buy
+629
New +$321K ﹤0.01% 1277

Other funds holding MDGL

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return

M&T Bank's MDGL Position: Q3 2026 in Review

M&T Bank reduced its Madrigal Pharmaceuticals (MDGL) stake by 1.4% in Q3 2026, selling an estimated $5.81K and leaving 803 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

M&T Bank first reported a position in MDGL in Q4 2025 and has held it in 4 quarters since. The position peaked at $438K in Q2 2026. 278 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • M&T Bank held 803 shares of Madrigal Pharmaceuticals worth $405K as of Q3 2026.
  • M&T Bank sold 11 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $5.81K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1299 holding.
  • M&T Bank first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • M&T Bank's Madrigal Pharmaceuticals position peaked at $438K in Q2 2026.
  • 278 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.